1 / 38

Kuidas hoida oma tervist kui olete juba haigestunud 2 t pi diabeeti

Teemad. Veresuhkru head v??rtusedMis on HbA1c? Mida see anal??s n?itab?Milliseid anal??se tuleks patsiendile teha?Milliseid uuringuid tuleks patsiendile teha?Kokkuv?teK?simused patsientidele. Kui k?rged peaksid olema Teie veresuhkrud?. EDMOND Kliinik. Head veresuhkru v??rtused. Kui tihti tuleks veresuhkruid m??ta?.

bjorn
Télécharger la présentation

Kuidas hoida oma tervist kui olete juba haigestunud 2 t pi diabeeti

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


    1. Kuidas hoida oma tervist kui olete juba haigestunud 2 tpi diabeeti? Verner Fogel 2010

    2. Teemad Veresuhkru head vrtused Mis on HbA1c? Mida see anals nitab? Milliseid analse tuleks patsiendile teha? Milliseid uuringuid tuleks patsiendile teha? Kokkuvte Ksimused patsientidele

    3. Kui krged peaksid olema Teie veresuhkrud?

    4. Head veresuhkru vrtused

    5. Kui tihti tuleks veresuhkruid mta? Kui 2 tpi diabeet on alles diagnoositud vi veresuhkrud ei ole normipiirides Mtke veresuhkrut le peva Hommikul enne ski Enne luna-ja htuski 2 tundi peale ski Enne uinumist Veresuhkru vrtused kirjutage pevikusse Pevik vtke alati arsti vastuvtule kaasa, sest veresuhkru vrtustest sltub Teie edasine ravi

    6. Kui tihti tuleks veresuhkruid mta? Kui Teie veresuhkrud on normipiirides Mtke veresuhkrut 1-2 korda ndalas Hommikul enne ski Enne luna-ja htuski 2 tundi peale ski Enne uinumist Veresuhkru vrtused kirjutage pevikusse Pevik vtke alati arsti vastuvtule kaasa sest veresuhkru vrtustest sltub Teie edasine ravi

    7. Thjakhu krgete veresuhkrute thtsus diabeedi kompensatsioonis This study analysed the diurnal glycaemic profiles of 290 patients with T2DM investigated at different levels of HbA1c. The patients were treated with diet or oral hypoglycaemic agents (not acarbose). Plasma glucose (PG) concentrations were determined at fasting and during postprandial and post absorptive periods. The areas under the curve above fasting PG concentrations and >6.1 mmol/l (110 mg/dl) were calculated for further evaluation of the relative contributions of postprandial and fasting PG increments to the overall diurnal hyperglycaemia. The value of 6.1 mmol/l (110 mg/dl) was chosen because this threshold has been defined as the upper limit of normal PG at fasting or preprandial times by the American Diabetes Association. The data were compared over quintiles of HbA1c. The main contributor to overall hyperglycaemia in patients with poorly controlled T2DM was found to be fasting hyperglycaemia. Fasting hyperglycaemia was the dominant factor in patients who were furthest from HbA1c target. Monnier L, et al. Diabetes Care 2003;26:881?5.This study analysed the diurnal glycaemic profiles of 290 patients with T2DM investigated at different levels of HbA1c. The patients were treated with diet or oral hypoglycaemic agents (not acarbose). Plasma glucose (PG) concentrations were determined at fasting and during postprandial and post absorptive periods. The areas under the curve above fasting PG concentrations and >6.1 mmol/l (110 mg/dl) were calculated for further evaluation of the relative contributions of postprandial and fasting PG increments to the overall diurnal hyperglycaemia. The value of 6.1 mmol/l (110 mg/dl) was chosen because this threshold has been defined as the upper limit of normal PG at fasting or preprandial times by the American Diabetes Association. The data were compared over quintiles of HbA1c. The main contributor to overall hyperglycaemia in patients with poorly controlled T2DM was found to be fasting hyperglycaemia. Fasting hyperglycaemia was the dominant factor in patients who were furthest from HbA1c target. Monnier L, et al. Diabetes Care 2003;26:881?5.

    8. Suremus ja sgijrgne veresuhkur In this study, PPG was found to be an independent and progressive risk factor for mortality. 1. DECODE Study Group. Lancet 1999; 354: 61721.In this study, PPG was found to be an independent and progressive risk factor for mortality. 1. DECODE Study Group. Lancet 1999; 354: 61721.

    9. Mis asi on glkohemoglobiin? Mida see anals nitab?

    10. Mida nitab HbA1c? A1c nitab kui palju veresuhkrust on seotud punalibledes hapnikku transportiva valguga Nitab 2-3 kuu keskmist veresuhkru taset A1c tase sltub hommikusest thjakhu veresuhkru vrtusest A1c on hea, siis tuleks veresuhkruid kontrollida ka 2 tundi peale ski Ei anna informatsiooni madalate veresuhkrute ja lhiaegsete veresuhkru muutuste kohta

    11. HbA1c ehk anals mis nitab Teie 3 kuu keskmist veresuhkrut Diabeet on hsti ravitud HbA1c on antud juhul alla 7% Kontrollitakse 2 korda aastas

    12. HbA1c ehk anals mis nitab Teie 3 kuu keskmist veresuhkrut Diabeet on halvasti ravitud HbA1c on antud juhul le 7% Kontrollitakse 4 korda aastas

    13. HbA1C ja vikeste veresoonte tsistuste tekkimise risk Good glycaemic control is essential to reduce the risk of diabetic complications Based on the Diabetes Control and Complications Trial data, the relative risk for microvascular complications such as diabetic retinopathy, nephropathy, neuropathy, and microalbuminuria increases with increasing levels of A1C1-3 The relative risk of complications is set to 1 for an A1C of 6%1 It is important to note that the risk gradient is continuous, with no glycaemic threshold for developing complications1Good glycaemic control is essential to reduce the risk of diabetic complications Based on the Diabetes Control and Complications Trial data, the relative risk for microvascular complications such as diabetic retinopathy, nephropathy, neuropathy, and microalbuminuria increases with increasing levels of A1C1-3 The relative risk of complications is set to 1 for an A1C of 6%1 It is important to note that the risk gradient is continuous, with no glycaemic threshold for developing complications1

    15. HbA1c langetamine vhendab tsistuste riski Data from the UKPDS demonstrated the substantial impact of good glycemic control on microvascular and macrovascular complications. In an analysis of these data, it was estimated that a 1% decrease in HbA1c, which reflects a measure of glycemia over the past 23 months, correlates with: 21% reduction in the risk of deaths related to diabetes (P < 0.0001)? 37% reduction in the risk of microvascular complications (P < 0.0001)? 14% reduction in the risk of myocardial infarction (P < 0.0001). These striking reductions in risk form the basis for diabetes management guidelines recommending aggressive targets for HbA1c in individuals with type 2 diabetes. Stratton IM, et al. BMJ 2000; 321:405412.Data from the UKPDS demonstrated the substantial impact of good glycemic control on microvascular and macrovascular complications. In an analysis of these data, it was estimated that a 1% decrease in HbA1c, which reflects a measure of glycemia over the past 23 months, correlates with: 21% reduction in the risk of deaths related to diabetes (P < 0.0001)? 37% reduction in the risk of microvascular complications (P < 0.0001)? 14% reduction in the risk of myocardial infarction (P < 0.0001). These striking reductions in risk form the basis for diabetes management guidelines recommending aggressive targets for HbA1c in individuals with type 2 diabetes. Stratton IM, et al. BMJ 2000; 321:405412.

    16. Milliseid analse tuleks veel teha diabeeti pdevatele patsientidele?

    17. Teised vajalikud analsid Kolesteroolid Valk hommikuses uriinis Vajadusel mikroobide anals uriinist

    18. Kolesteroolide kontroll

    19. Teised vajalikud analsid Kolesteroolide vrtused 2 tpi diabeetikul: ldine kolesterool alla 4,5 mmol/l Hea kolesterool ( ehk HDL) le 1,1 mmol/l Halb kolesterool ( ehk LDL) infarkti vi insuldi anamneesita alla 2,5 mmol/l Halb kolesterool ( ehk LDL) infarkti vi insuldi anamneesiga alla 1,8 mmol/l Trigltseriidid( ehk rasvhapped) alla 1,7 mmol/l

    20. Teised vajalikud analsid Kolesterool koguneb veresoonte seintesse Tekivad naastud, mis halvendavad verevarustust Suured naastud lhevad katki ja sinna piirkonda tekib tromb Trombi tekkimine phjustab infarkti, insulti ja jalgade gangreeni

    22. Teised vajalikud analsid Kui Teie kolesteroolid on raviga vi ravita normipiirides, siis korratakse analse 1 kord aastas Kui Teie kolesteroolid ravil vi ravita on krged, siis korratakse analse 3 kuu tagant Kui kolesteroolid ei ole normipiirides, siis tuleks ravi muuta vi ravi alustada

    23. Neerude kontroll

    24. Teised vajalikud analsid Valk uriinis nitab, kas Teil esineb neerude kahjustust vi mitte Diagnoosimiseks peab olema 2 analsi le normi Albumiini kreatiniini suhe meestel peaks olema alla 2 ja naistel alla 3

    25. Teised vajalikud analsid Kui esimene anals ei ole korras, siis tuleks teha teine anals 2-3 kuu prast Kui 2 analsi olid korras vi juba varasemalt neerude kahjustus teada, siis korratakse analsi 1 kord aastas

    26. Teised vajalikud analsid Kuidas parandada vi ra hoida valgu sattumist uriini Teie veresuhkrud peavad olema normipiirides Teie vererhk peab olema normipiirides Pletiku ravimine neerudes vi kusepies

    27. Teised vajalikud analsid 1 kord aastas tuleb kontrollida neerude analse verest ( kreatiniin ja uurea)

    28. Teised vajalikud analsid Mikroobide kontroll uriinist Kui esinevad kaebused sagedale urineerimisele, seljavalule, krvetustundele urinineerimisel Analsi tuleks korrata kaebuste taastekkimisel Raviks kasutatakse antibiootikume

    29. Milliseid uuringuid tuleks teha 2 tpi diabeetikul?

    30. Vajalikud uuringud Igal vastuvtul tuleks mta vererhku Neerukahjustuseta patsiendil peaks vererhk olema alla 130/80 mmHg Neerukahjustusega patsiendil peaks vererhk olema alla 125/75 mmHg

    31. Vajalikud uuringud 1 kord aastas tuleb kia silmaarsti juures Silmaarst vaatab, kas Teil on muutusi silmaphjades Silmaarst vaatab, kas Teil on kaed vi silmasisese rhu tusu

    32. Vajalikud uuringud 1 kord aastas katsutakse pulsse jalgadel ja kontrollitakse haavandite olemasolu jalgadel Vajalik veresoontes olevate ahenemiste varajaseks leidmiseks Vajalik nrvikahjustuse uurimiseks Vajalik haavandite varajaseks avastamiseks ja gangreeni ning amputatsiooni rahoidmiseks

    33. Soovitused patsiendile Kui tulete arsti vastuvtule, siis Vtke oma kingad vi saapad jalast Vtke kaasa oma koduste vererhkude nidud Rkige oma kodustest probleemidest ( jalad, vererhk, silmad)

    34. Kokkuvte Hoidke veresuhkrud normipiirides Hoidke vererhk normipiirides Kige regulaarselt arsti juures kontrollis Kui veresuhkrud vi vererhud on le normi, siis prduge perearsti vi endokrinoloogi juurde Kige regulaarselt silmaarsti juures

    35. Ksimused Kui krged peaksid olema Teie veresuhkrud, et diabeet oleks hsti ravitud? Kui krge peaks olema Teie HbA1c, et diabeet oleks hsti ravitud? Kui tihti peaksite kima arsti juures, kui HbA1c on alla 7%? Kui tihti peaksite kima arsti juures, kui HbA1c on le 7%?

    36. Ksimused Mida nitab HbA1c? Milliseid analse ja uuringuid tuleks teha 2 tpi diabeetikul? Kui tihti tuleks kia silmaarsti vastuvtul? Kas krget kolesterooli on vaja ravida?

    37. Ksimused Milleks on vaja kolesterooli ravida? Kui kolesterool ei ole korras ravil, millal tuleks uuesti kontrollida? Kui krge viks olla diabeetikul vererhk, et lugeda seda normipiirides olevaks? Kui tihti tuleks teha neeruanalse? Kas peaksite arsti juurde minnes kaasa vtma kodused veresuhkrud ja vererhud?

    38. Hoidke oma tervist! Teie elate ainult he korra!

    39. Tnan!

More Related